|
1
|
Gawlik K, Shiryaev SA and Zhu W:
Autocatalytic activation of the furin zymogen requires removal of
the emerging enzyme’s N-terminus from the active site. PLoS One.
4:e50312009.PubMed/NCBI
|
|
2
|
Vey M, Schäfer W, Berghöfer S, Klenk HD
and Garten W: Maturation of the trans-Golgi network protease furin:
compartmentalization of propeptide removal, substrate cleavage, and
COOH-terminal truncation. J Cell Biol. 127:1829–1842. 1994.
View Article : Google Scholar
|
|
3
|
Creemers JW, Vey M, Schäfer W, Ayoubi TA,
Roebroek AJ, Klenk HD, Garten W and Van de Ven WJ: Endoproteolytic
cleavage of its propeptide is a prerequisite for efficient
transport of furin out of the endoplasmic reticulum. J Biol Chem.
270:2695–2702. 1995. View Article : Google Scholar
|
|
4
|
Anderson ED, VanSlyke JK, Thulin CD, Jean
F and Thomas G: Activation of the furin endoprotease is a
multiple-step process: requirements for acidification and internal
propeptide cleavage. EMBO J. 16:1508–1518. 1997. View Article : Google Scholar
|
|
5
|
Molloy SS, Thomas L, VanSlyke JK, et al:
Intracellular trafficking and activation of the furin proprotein
convertase: localization to the TGN and recycling from the cell
surface. EMBO J. 13:18–33. 1994.PubMed/NCBI
|
|
6
|
Fujisawa T, Kamimura H, Hosaka M, et al:
Functional localization of proprotein-convertase furin and its
substrate TGFbeta in EGF receptor-expressing gastric chief cells.
Growth Factors. 22:51–59. 2004. View Article : Google Scholar
|
|
7
|
Louagie E, Taylor NA, Flamez D, et al:
Role of furin in granular acidification in the endocrine pancreas:
identification of the V-ATPase subunit Ac45 as a candidate
substrate. Proc Natl Acad Sci USA. 105:12319–12324. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yana I and Weiss SJ: Regulation of
membrane type-1 matrix metalloproteinase activation by proprotein
convertases. Mol Biol Cell. 11:2387–2401. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dangi-Garimella S, Krantz SB, Barron MR,
et al: Three-dimensional collagen I promotes gemcitabine resistance
in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.
Cancer Res. 71:1019–1028. 2011. View Article : Google Scholar
|
|
10
|
López de Cicco R, Bassi DE, Zucker S, et
al: Human carcinoma cell growth and invasiveness is impaired by the
propeptide of the ubiquitous proprotein convertase furin. Cancer
Res. 65:4162–4171. 2005.PubMed/NCBI
|
|
11
|
Thomas G: Furin at the cutting edge: from
protein traffic to embryogenesis and disease. Nat Rev Mol Cell
Biol. 3:753–766. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nusse R and Varmus HE: Wnt genes. Cell.
69:1073–1087. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McMahon AP, Gavin BJ, Parr B, et al: The
Wnt family of cell signalling molecules in postimplantation
development of the mouse. Ciba Found Symp. 165:199–218.
1992.PubMed/NCBI
|
|
14
|
Polakis P: The many ways of Wnt in cancer.
Curr Opin Genet Dev. 17:45–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smalley MJ and Dale TC: Wnt signalling in
mammalian development and cancer. Cancer Metastasis Rev.
18:215–230. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y: Wnt/Planar cell polarity
signaling: a new paradigm for cancer therapy. Mol Cancer Ther.
8:2103–2109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katoh M: WNT/PCP signaling pathway and
human cancer (review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
18
|
Hecht A, Vleminckx K, Stemmler MP, et al:
The p300/CBP acetyltransferases function as transcriptional
coactivators of beta-catenin in vertebrates. EMBO J. 19:1839–1850.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takemaru KI and Moon RT: The
transcriptional coactivator CBP interacts with beta-catenin to
activate gene expression. J Cell Biol. 149:249–254. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Inagawa S, Itabashi M, Adachi S, et al:
Expression and prognostic roles of beta-catenin in hepatocellular
carcinoma: correlation with tumor progression and postoperative
survival. Clin Cancer Res. 8:450–456. 2002.
|
|
21
|
Wong CM, Fan ST and Ng IO: beta-Catenin
mutation and overexpression in hepatocellular carcinoma:
clinicopathologic and prognostic significance. Cancer. 92:136–145.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pulyaeva H, Bueno J, Polette M, Birembaut
P, Sato H, Seiki M and Thompson EW: MT1-MMP correlates with MMP-2
activation potential seen after epithelial to mesenchymal
transition in human breast carcinoma cells. Clin Exp Metastasis.
15:111–120. 1997. View Article : Google Scholar
|
|
23
|
Takahashi M, Tsunoda T, Seiki M, Nakamura
Y and Furukawa Y: Identification of membrane-type matrix
metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in
human colorectal cancers. Oncogene. 21:5861–5867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Itoh Y and Seiki M: MT1-MMP: a potent
modifier of pericellular microenvironment. J Cell Physiol. 206:1–8.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kajita M, Itoh Y, Chiba T, Mori H, Okada
A, Kinoh H and Seiki M: Membrane-type 1 matrix metalloproteinase
cleaves CD44 and promotes cell migration. J Cell Biol. 153:893–904.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deryugina EI, Ratnikov BI, Postnova TI,
Rozanov DV and Strongin AY: Processing of integrin alpha(v) subunit
by membrane type 1 matrix metalloproteinase stimulates migration of
breast carcinoma cells on vitronectin and enhances tyrosine
phosphorylation of focal adhesion kinase. J Biol Chem.
277:9749–9756. 2002. View Article : Google Scholar
|
|
28
|
Overall CM: Molecular determinants of
metalloproteinase substrate specificity: matrix metalloproteinase
substrate binding domains, modules, and exosites. Mol Biotechnol.
22:51–86. 2002. View Article : Google Scholar
|
|
29
|
Harada T, Arii S, Mise M, Imamura T,
Higashitsuji H, et al: Membrane-type matrix
metalloproteinase-1(MT1-MMP) gene is overexpressed in highly
invasive hepatocellular carcinomas. J Hepatol. 28:231–239. 1998.
View Article : Google Scholar
|
|
30
|
Arii S, Mise M, Harada T, Furutani M,
Ishigami S, Niwano M, et al: Overexpression of matrix
metalloproteinase-9 gene in hepatocellular carcinoma with invasive
potential. Hepatology. 24:316–322. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagase H, Visse R and Murphy G: Structure
and function of matrix metalloproteinases and TIMPs. Cardiovasc
Res. 69:562–573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kähäri VM and Saarialho-Kere U: Matrix
metalloproteinases and their inhibitors in tumour growth and
invasion. Ann Med. 31:34–45. 1999.PubMed/NCBI
|
|
34
|
Sato H, Takino T, Okada Y, Cao J, Shinagaw
A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on
the surface of invasive tumour cells. Nature. 370:61–65. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sounni NE and Noel A: Membrane type-matrix
metalloproteinases and tumor progression. Biochimie. 87:329–342.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sato H, Takino T and Miyamori H: Roles of
membrane-type matrix metalloproteinase-1 in tumor invasion and
metastasis. Cancer Sci. 96:212–217. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Seiki M: Membrane-type 1 matrix
metalloproteinase: a key enzyme for tumor invasion. Cancer Lett.
194:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Holmbeck K, Bianco P, Yamada S and
Birkedal-Hansen H: MT1-MMP: a tethered collagenase. J Cell Physiol.
200:11–19. 2004. View Article : Google Scholar : PubMed/NCBI
|
